BCM
PGNX

Beryl Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Beryl Capital Management’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-714,084
Closed -$2.71M – 71
2020
Q1 		$2.71M Buy
+714,084
New +$2.71M 0.57% 18